Medication info
Almantin Tablets 5mg (Memantine Hydrochloride)

Almantin Tablets 5mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›5mg / 1 tablet
Manufacturer / importer
Allico Pharmaceutical Co., Ltd.
Appearance
Yellow rectangular film-coated tablets
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202500201 · Approved 2025.01.24 · Insurance code 656005660

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered 2 times daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. First week (Day 1~7): Administer 5mg once daily for 7 days. Second week (Day 8~14): Administer 10mg once daily for 7 days. Third week (Day 15~21): Administer 15mg once daily for 7 days. From the fourth week onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg once daily according to the standard dose-escalation method after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is advisable not to administer this medicine.

Ingredients

Manufacturer
Allico Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered 2 times daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. First week (Day 1~7): Administer 5mg once daily for 7 days. Second week (Day 8~14): Administer 10mg once daily for 7 days. Third week (Day 15~21): Administer 15mg once daily for 7 days. From the fourth week onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg once daily according to the standard dose-escalation method after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is advisable not to administer this medicine.

Precautions

This medication should not be used in patients who have an allergy to its ingredients. It should not be administered to patients with very poor liver function or severely impaired kidney function. Caution should be exercised in patients with a history of seizures or epilepsy while using this medication. Serious side effects may occur when taken together with certain medications, so consultation with a doctor is essential. Patients with changes in the acidity of urine should carefully monitor their urine condition. Caution is also necessary for patients with uncontrolled heart diseases or hypertension, as the safety of this medication is not fully established. This medication contains specific dyes, so patients allergic to these components should be careful. Symptoms such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and patients should consult a doctor if symptoms are severe. This medication may interact with other drugs, so any other medications being taken must be disclosed. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, and breastfeeding mothers are advised to discontinue breastfeeding. Use in children or adolescents under 18 years of age is not recommended due to insufficient evidence of safety and efficacy. In case of overdose, central nervous system symptoms or gastrointestinal symptoms may appear, so immediate medical attention should be sought. Caution is advised when driving or operating machinery while taking this medication. Keep out of reach of children and do not transfer the medication to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucination
  • psychotic reaction
Show 25 more
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • venous thrombosis/thromboembolism
  • difficulty breathing
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • abnormal stupor
  • double vision
  • agitation
  • restlessness
  • psychosis
  • visual hallucination
  • delirium
  • unconsciousness
  • lethargy
  • fatigue
  • weakness
  • diarrhea
  • agitation
  • aggression

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is advisable to keep it at temperatures between 1 degree and 30 degrees Celsius. Storing it this way can help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Yellow rectangular film-coated tablets

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.